Navigation Links
Everolimus slows disease progression in advanced papillary kidney cancer patients
Date:9/27/2013

-free survival was 7.6 months, according to the central review it was 3.7 months, and more than half of the patients were alive at 21 months.

"These results underline the differences that are often observed between local investigator assessment and central review according to the established set of rules used to evaluate anti-cancer drugs.

"As far as we know, this study is unique as it was the first study of an mTOR inhibitor to only include patients with advanced papillary kidney cancer and diagnosis was also confirmed by an independent group of pathologists experienced in the classification of kidney cancer to prevent any tumours being classified incorrectly.

"Everolimus represents another interesting treatment option for advanced papillary kidney cancer patients as it seems to extend their survival and time without the disease progressing."

Adverse side-effects were generally well tolerated. They included weakness, tiredness and anaemia; 27% of patients discontinued everolimus due to these side-effects. "The typical patient being treated for advanced papillary kidney cancer is middle-aged, active and still working, and the impact of side-effects may be more important to them," he will say.

"While the results from this Phase II study are encouraging, a Phase III trial would need to be done to fully characterise the efficacy and safety profile of everolimus in this patient population," he will conclude.

President of ECCO, Professor Cornelis van de Velde, commented: "Papillary tumours have been excluded from many of the targeted therapy trials. This study on targeting the mTOR pathway in patients with advanced papillary kidney cancer provides a basis for a Phase III trial and is potentially practice changing. It also emphasises the need for expert pathology, since central review gave markedly different results than local review."

ESMO spokesperson, Professor Manuela Schmidinger, Professor of Medicine
'/>"/>

Contact: Kay Roche
kay@rochewriting.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Thwarting protein production slows cancer cells malignant march
2. Aging - Daily Sunscreen Use Slows the Visible Signs of Aging Skin
3. Skin Care – Sunscreen Slows Skin Aging
4. Skin Care – Daily Sunscreen Use Slows Skin Aging
5. Scientists discover how rapamycin slows cell growth
6. Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency
7. Low-protein diet slows Alzheimers in mice
8. Newly approved oral medication slows rheumatoid arthritis joint damage
9. Active lifestyle boosts brain structure and slows Alzheimer’s disease
10. Mesothelioma drug slows disease progression in patients with an inactive NF2 gene
11. Mild HIV type slows development of AIDS and makes new preventive treatments possible
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... HealthDay Reporter , WEDNESDAY, Nov. 26, ... acquire a second language, new research suggests. But anyone who ... a brain boost, the small study finds. The ... co-author Ping Li, co-director of the Center for Brain, Behavior ... interesting, Li said, that "the brain networks of the more ...
(Date:11/27/2014)... PITTSBURGH, PA (PRWEB) November 27, 2014 In ... an inventor from Sharpes, Fla., designed an easy way to ... lowering it/them. , He then created a prototype of the ... lift or lower a toilet seat and/or lid in a ... which prevents the spread of germs. Overall, it promotes good ...
(Date:11/27/2014)... New York, New York (PRWEB) November 27, 2014 ... behalf of individuals who were allegedly injured by the ... court, where a federal litigation is looking ahead to ... , According to a Scheduling Order issued earlier ... take place on December 16th at 10:00 a.m. Items ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 “LAB.C” was featured ... features the latest and coolest technology products available to consumers. ... the product review and shared with viewers the ... iOS and Android devices. , Consumers love portability and functionality. ... Their Cable Case for the iPhone5 and 5S has a ...
(Date:11/27/2014)... HealthPostures, a leading national ... has announced that it has entered into a ... partnership will put HealthPostures' products into central Indiana’s ... addition to having its products sold through Commercial ... products with the business decision makers in the ...
Breaking Medicine News(10 mins):Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 3Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2Health News:Ergonomics Manufacturer Announces New Partnership with Office Supply Dealer 2
... suffering from serious hearing problems could have been benefited by ... is keeping them away, health experts said Saturday. ... hearing problems and about a million are children and they ... of the device is proving a hindrance," said Vice Admiral ...
... of Illinois at Urbana-Champaign have developed a simple, disposable ... rivals the performance of much more sophisticated laboratory instruments. ... test for assessing uranium contamination in the environment, and ... chemistry professor at Illinois and senior author of a ...
... its symbol back.It has notified public sector Indian Oil Corporation (IOC) ... using its red-colored cross symbol at pump outlets and other services ... chairman of Indian Oil telling him to direct petrol pump owners ... for the IRCS. ,The Geneva Conventions Act of 1960 ...
... is said to be vulnerable to a specific health ... colleagues from Institute for Clinical Evaluative Sciences in Toronto. ... more prone to pelvic fractures and Pisceans should be ... women born under the sign of Virgo vomit more ...
... A new lasercomb which promises hair growth in the scalp ... as Hairmax Lasercomb is manufactured by Lexington International LLC, a ... of low-level laser technology in a comb which when passed ... used by both men and women. The company’s website reveals ...
... their heart's content, brave young hearts battling cancer and those ... message - the disease is curable. ,The occasion ... Day. ,Prabhasimran Anand, a bubbly eight-year-old, who is ... "I am fighting blood cancer. I also go to school ...
Cached Medicine News:Health News:Need for Cost-effective Hearing Implants 2Health News:DNA-based Detection of Heavy Metals 2Health News:Health Disorders Linked To Astrological Signs 2Health News:Spirited, Smiling Young Warriors Take on Cancer 2
(Date:11/27/2014)... Ireland , November 27, 2014 ... Investigational New Drug (IND) Application with the U.S. Food ... in Hovione,s strategy of developing improved drug delivery options ... for minocycline gel, a novel formulation using a new ... one of the most widely prescribed oral antibiotics for ...
(Date:11/26/2014)... Company plc ("Perrigo") (NYSE: PRGO ; TASE), ... today announced the closing of Perrigo,s previously announced registered ... shares at a public offering price of $152.00 per ... purchase up to an additional 888,157 ordinary shares by ... representatives of the several underwriters. Perrigo ...
(Date:11/26/2014)... , Nov. 26, 2014  Avanir Pharmaceuticals, ... the U.S. Food and Drug Administration (FDA) has ... Drug Application (NDA) for AVP-825. AVP-825 is an ... powder delivered intranasally utilizing a novel Breath Powered ... Response letter, and consistent with the preliminary feedback ...
Breaking Medicine Technology:Hovione Files its First Investigational New Drug Application With the FDA 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 4Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4
... Cauteries provide a broad selection of ... wide variety of ophthalmic procedures. Each ... complete with a safety cap to ... position when not in use, and ...
... a broad selection of tip styles ... of ophthalmic procedures. Each single use ... a safety cap to lock switch ... not in use, and carries a ...
... Accu-Temp Cauteries provide a broad selection ... a wide variety of ophthalmic procedures. ... sterile, complete with a safety cap ... " position when not in use, ...
... Luminary LASIK Light Probes provide the surgeon ... the corneal interface to be easily visualized ... the Tindal effect and light scatter technique, ... debris, epithelial deposits, flap edge folds, corneal ...
Medicine Products: